Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Market Closed - BME 11:35:14 2026-09-18 am EDT			5-day change	1st Jan Change
57.65 ^EUR	-1.71%		+0.52%	-9.21%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Consensus
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.38B		BBB
ELI LILLY AND COMPANY	1,028B		A
JOHNSON & JOHNSON	651B	-	BBB	-		-
ABBVIE INC.	466B		AAA			-
ROCHE HOLDING AG	346B		AA
NOVARTIS AG	266B		AAA
ASTRAZENECA PLC	259B		A
AMGEN INC.	208B		A
NOVO NORDISK A/S	191B		BBB
GILEAD SCIENCES, INC.	186B		AA
PFIZER INC.	158B		A
VERTEX PHARMACEUTICALS INCORPORATED	129B		AA
BRISTOL-MYERS SQUIBB COMPANY	129B		A
SANOFI	102B		A
GSK PLC	101B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	70.71B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	60.71B		AA
BAYER AG	54.18B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	45.42B		A		-	-	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	43.2B		AA
Average	224.85B		AA
Weighted average by Cap.			AA